An in-depth look to SHINPOONG PHARMACEUTICAL operating, investing, and financing activities

019170 free cash flow for Q3 24 is 5.04 B KRW. For 2023, 019170 free cash flow was -39.74 B KRW and operating cash flow was -24.85 B KRW.